Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
U M Jadhav, A Kulkarni
No abstract text is available yet for this article.
July 2016: Journal of the American Society of Hypertension: JASH
#2
REVIEW
Metabolic actions of angiotensin receptor antagonists: PPAR-gamma agonist actions or a class effect?
Paul Ernsberger, Richard J Koletsky
Accumulating basic and clinical data support the hypothesis that angiotensin receptor blockers have beneficial effects on glucose and lipid metabolism that are not shared by other classes of antihypertensive agents. These metabolic actions might only partially be shared by angiotensin-converting enzyme inhibitors. Specific benefits beyond those of other angiotensin receptor blockers have been claimed for telemesartan and, to a lesser extent, irbesartan based on a partial agonist action on PPAR-gamma receptors...
April 2007: Current Opinion in Pharmacology
1
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
